Join to View Full Profile
1100 Fairview Ave NMail Stop M1-B140Seattle, WA 98109
Phone+1 206-667-7485
Fax+1 206-667-1965
Dr. Uldrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
 - Connect with colleagues in the same hospital or clinic.
 - Read the latest clinical news, personalized to your specialty.
 
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2005 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
State University of New York Downstate Medical Center College of MedicineClass of 2002
Certifications & Licensure
WA State Medical License 2017 - 2026
NY State Medical License 2004 - 2021
Clinical Trials
- Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer Start of enrollment: 2016 Apr 04
 - Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Start of enrollment: 2017 Jul 03
 - Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda Start of enrollment: 2019 Oct 24
 
Publications & Presentations
PubMed
- Cytokine biomarkers and their relationship to symptoms and quality of life in people with HIV-associated Kaposi sarcoma.Fahmida Shaik, Thomas Smith Uldrick, Mikateko Mazinu, Nomonde Gwebushe, Anisa Mosam
HIV Medicine. 2025-09-10 - Characteristics and outcomes of Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS).Ramya Ramaswami, Kathryn Lurain, Mark N Polizzotto, Anaida Widell, Irene Ekwede
Blood Advances. 2025-08-05 - 1 citationsPhase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda.Manoj P Menon, Henry Ddungu, Kelvin R Mubiru, Scott V Adams, Jacqueline Asea
JCO Global Oncology. 2025-04-01 
Journal Articles
- Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNARamya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences
 - International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman DiseaseAaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood
 
Abstracts/Posters
- Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients...Thomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
 - High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic TrialsThomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
 - Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R2) in Primary Effusion Lymphoma in Patients with or without HIVThomas S. Uldrick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
 
Press Mentions
Cancer Immunotherapy Flushes HIV Out of HidingFebruary 9th, 2022
Cancer Drug Flushes Out Latent HIV, Exciting New Study FindsJanuary 28th, 2022
Anti-Cancer Drug Can Flush Out HIV Hiding in Cells, Study SuggestsJanuary 27th, 2022- Join now to see all
 
Professional Memberships
- Member
 
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










